Tauser, R.-G.; Lupascu, F.-G.; Profire, B.-S.; Iacob, A.-T.; Vasincu, I.-M.; Apotrosoaei, M.; Chirliu, O.-M.; Lupascu, D.; Profire, L.
Aptamer-Nanoconjugates as Potential Theranostics in Major Neuro-Oncological and Neurodegenerative Disorders. Pharmaceutics 2025, 17, 1106.
https://doi.org/10.3390/pharmaceutics17091106
AMA Style
Tauser R-G, Lupascu F-G, Profire B-S, Iacob A-T, Vasincu I-M, Apotrosoaei M, Chirliu O-M, Lupascu D, Profire L.
Aptamer-Nanoconjugates as Potential Theranostics in Major Neuro-Oncological and Neurodegenerative Disorders. Pharmaceutics. 2025; 17(9):1106.
https://doi.org/10.3390/pharmaceutics17091106
Chicago/Turabian Style
Tauser, Roxana-Georgiana, Florentina-Geanina Lupascu, Bianca-Stefania Profire, Andreea-Teodora Iacob, Ioana-Mirela Vasincu, Maria Apotrosoaei, Oana-Maria Chirliu, Dan Lupascu, and Lenuta Profire.
2025. "Aptamer-Nanoconjugates as Potential Theranostics in Major Neuro-Oncological and Neurodegenerative Disorders" Pharmaceutics 17, no. 9: 1106.
https://doi.org/10.3390/pharmaceutics17091106
APA Style
Tauser, R.-G., Lupascu, F.-G., Profire, B.-S., Iacob, A.-T., Vasincu, I.-M., Apotrosoaei, M., Chirliu, O.-M., Lupascu, D., & Profire, L.
(2025). Aptamer-Nanoconjugates as Potential Theranostics in Major Neuro-Oncological and Neurodegenerative Disorders. Pharmaceutics, 17(9), 1106.
https://doi.org/10.3390/pharmaceutics17091106
